Buy Apretude Online

Apretude is a long-acting injectable PrEP medicine containing cabotegravir. It can be bought online for clinic-administered HIV-1 prevention, with the 600 mg single-dose vial matched to the dosing plan your healthcare professional has set. Choose the strength and quantity shown during ordering carefully, because this medicine is prepared and given by a trained clinician rather than injected at home.

Apretude is used to help reduce the risk of sexually acquired HIV-1 infection in at-risk adults and adolescents who weigh at least 35 kg. It is not a treatment for established HIV infection. Safe use depends on scheduled injections, required HIV testing, and follow-up visits that stay aligned with your clinic’s plan.

If you are arranging Apretude US delivery from Canada, coordinate the vial, appointment date, storage expectations, and clinic handling rules before the dose is due. BorderFreeHealth may review order information and clinic-related documentation before release, and prompt, express shipping may be available when order and handling requirements are complete.

Apretude Price, Injection Cost, and Vial Details

The Apretude price should be assessed against the actual form and strength being ordered. This medicine is supplied as an extended-release injectable suspension, not a daily tablet, auto-injector, or self-injection device. The product described here is the Apretude 600 mg injection in a single-dose vial with a concentration of 200 mg/mL.

When estimating Apretude cost, separate the medicine charge from clinic services. The Apretude injection cost may involve administration fees, HIV testing, laboratory work, counseling, appointment charges, or follow-up visits that are billed outside the medicine order. This distinction matters for cash-pay planning and for people asking about Apretude cost without insurance.

The vial strength, concentration, and quantity should match what your clinic is prepared to use. A clinic may have its own receiving, storage, and medication-handling policies, so ask before sending or carrying medication to an appointment. Do not assume a clinic can administer a vial unless it has agreed to the plan.

Quick tip: Confirm the 600 mg vial and appointment date with the clinic before arranging shipment.

How to Buy Apretude Online

To buy Apretude online, select the cabotegravir injectable suspension strength shown for the medicine and align the order with the clinic visit. The practical goal is to have the correct vial available at the right time, without disrupting required HIV testing or the dosing window chosen by your healthcare professional.

Apretude Ships from Canada to US service context is most useful when you plan around timing and handling. Review the order quantity, clinic appointment, and receiving instructions together. If any documentation is requested, respond early so the pharmacy can complete its checks before the medicine is released.

Because Apretude administration must be performed by a clinician, home injection is not appropriate. The clinic should confirm how the vial will be stored, prepared, drawn up, and injected. If your appointment changes, tell the clinic and ordering team quickly so the medication plan can be reassessed.

What Apretude for PrEP Is Used For

Apretude for PrEP contains cabotegravir, an integrase strand transfer inhibitor. Integrase is an HIV enzyme the virus uses during replication. By blocking this step, the medication helps reduce the risk of acquiring HIV-1 from sexual exposure when injections are given on schedule.

Apretude medication is used for prevention in people who are HIV-negative before starting and remain HIV-negative during ongoing use. It is not used by itself to treat HIV. Starting or continuing PrEP during undiagnosed HIV infection can raise the risk of resistance, which is why testing is part of every safe Apretude plan.

Injectable PrEP may suit people who prefer a clinic-administered option instead of remembering a daily pill. It may be less practical for anyone who cannot reliably attend visits, expects frequent travel conflicts, or uses medicines that interact with cabotegravir. A healthcare professional can help decide whether long-acting PrEP fits your risk pattern and schedule.

For broader prevention context, What Is PrEP Medication explains how PrEP fits into HIV risk-reduction planning. The HIV condition category also brings together related HIV prevention and treatment topics.

Strength, Form, and Clinic Administration

Apretude injectable suspension is supplied as an extended-release intramuscular medicine. The Apretude dose described for this product is a 600 mg single-dose vial, equal to 3 mL of a 200 mg/mL cabotegravir suspension. The extended-release design supports less frequent dosing than daily oral PrEP, but it also makes appointment timing important.

Apretude administration is a deep intramuscular injection into the gluteal muscle. It should not be injected into a vein, under the skin, or into the thigh. Clinics may observe patients after the shot, particularly around early doses, so allow enough time for the full visit.

Apretude dosing commonly begins with initiation injections followed by maintenance injections every two months. Some people may use an oral cabotegravir lead-in to assess tolerability before the first injection if the clinician chooses that approach. Do not change an Apretude dosage schedule on your own, because late, early, or missed injections need a clinical plan.

Testing, Timing, and Missed Apretude Shots

HIV testing is required before starting Apretude and before ongoing injections. Testing helps confirm the medicine is still being used for prevention rather than during an undiagnosed infection. Your clinic may also ask about recent exposures, symptoms that could suggest acute HIV, and whether additional testing is needed.

If an Apretude shot will be delayed, contact the clinic as soon as possible. Cabotegravir remains in the body for a long time after injections stop. During a prolonged gap, low remaining drug levels may be a concern if HIV exposure occurs, so the clinic may discuss oral bridging or another prevention plan.

Do not try to correct a missed visit by changing the schedule yourself. The clinic will decide whether the same schedule can continue, whether re-initiation is needed, or whether another PrEP option is safer. Calendar reminders, text alerts, and booking several visits ahead can help protect the dosing window.

If you want to prepare risk-related questions before an appointment, How Is HIV Transmitted explains common exposure routes. How Does HIV Spread covers related transmission basics in plain language.

Storage, Handling, and Travel Planning

Apretude vials should be stored and handled according to labeled conditions and clinic instructions. Keep the vial in its original packaging until preparation. Protect it from unsuitable temperatures, avoid freezing, and keep it away from children and pets.

Injectable PrEP requires more planning than a tablet because a clinic must administer it. If you travel, arrange the injection before leaving or ask whether another clinic can manage the visit. If you personally transport the vial between a pharmacy and clinic, follow packaging and handling directions exactly.

Travel documentation can reduce confusion. Carry order information, appointment details, and any paperwork the clinic recommends. Do not pack the vial loosely in luggage or expose it to heat, cold, or direct light beyond labeled instructions.

Why it matters: Handling errors can affect whether a clinic can safely use the vial.

Side Effects, Warnings, and Monitoring

The most common Apretude side effects involve the injection site. These reactions may include pain, tenderness, swelling, firmness, redness, itching, bruising, warmth, or a small lump. Many are mild to moderate, but severe, worsening, or persistent injection-site symptoms should be reported to the clinic.

Other reported effects can include headache, fever, chills, fatigue, muscle aches, joint pain, nausea, vomiting, sleep changes, dizziness, or rash. Mood changes may occur in some people. Tell a healthcare professional if symptoms feel unusual, interfere with daily activities, or appear after a new medicine is started.

Serious reactions need urgent medical attention. Seek help for rash with fever, swelling, trouble breathing, severe tiredness, dark urine, yellowing skin or eyes, or thoughts of self-harm. Liver problems and hypersensitivity reactions are important safety concerns with cabotegravir.

Apretude remains in the body for months after the last injection. That long tail is one reason follow-up matters after stopping. If HIV infection occurs while cabotegravir levels are too low to fully protect, resistant virus may develop and future treatment choices may be affected.

Drug Interactions and Who Should Use Caution

Cabotegravir is affected by UGT1A1 metabolism. Strong enzyme inducers can lower cabotegravir levels and may reduce effectiveness. Important examples include rifampin, rifapentine, carbamazepine, phenytoin, phenobarbital, and oxcarbazepine.

Before using Apretude, give the clinic a current list of medicines, supplements, and herbal products. Include seizure medicines, tuberculosis medicines, over-the-counter products, and recent short courses of treatment. Interaction review is especially important because the injectable medicine cannot be quickly removed after administration.

Use extra caution if you have a history of liver disease, significant allergic reactions, or depression. People who are pregnant, planning pregnancy, or breastfeeding should discuss known and unknown risks with a healthcare professional. Apretude for women is not limited by sex, but reproductive health planning can affect monitoring choices.

Condoms, STI screening, and risk-reduction counseling may still be part of a complete prevention plan. Injectable PrEP helps reduce HIV-1 risk when used correctly, but it does not protect against other sexually transmitted infections.

Apretude Generic Status and Related PrEP Choices

There is currently no approved Apretude generic for PrEP in the United States. If another cabotegravir product is discussed, confirm whether it is approved for HIV-1 PrEP and whether it matches the intended injectable presentation. Brand and generic status can differ by country, so use the exact medication your clinician has planned.

Injectable PrEP Apretude can reduce the daily task burden of taking pills. The tradeoff is that clinic visits, HIV testing, and missed-dose planning become central to safe use. A long-acting injection is not interchangeable with daily oral PrEP tablets unless a healthcare professional changes the prevention plan.

Oral PrEP products such as Descovy and Tavin EM use different active ingredients and dosing routines. The Antivirals category can help you browse broader antiviral product choices, while Biktarvy and PEP use explains why HIV prevention and treatment products should not be substituted casually.

Questions to Ask Before Your Clinic Visit

Bring focused questions to the clinic before the first injection. Clear answers make it easier to match the vial, appointment timing, and monitoring plan. Written notes are useful if more than one clinic or pharmacy is involved in receiving or handling the medication.

• Candidate fit: Ask whether long-acting PrEP suits your risk pattern and visit schedule.
• Lead-in choice: Ask whether oral cabotegravir is needed before the first injection.
• Testing plan: Confirm which HIV tests are required before each dose.
• Timing gaps: Ask what to do if travel or illness delays a visit.
• Interaction check: Review seizure, tuberculosis, herbal, and other medicines.
• Clinic handling: Confirm whether the clinic can receive, store, and administer the vial.
• Cost planning: Ask which testing or administration fees are separate from the medicine.

If your risk situation changes, ask whether your PrEP plan should change too. The article Can You Get HIV From Someone Undetectable may help frame questions about ongoing exposure risk and prevention needs.

Authoritative Sources

Official label details are available through DailyMed Apretude prescribing information. FDA approval background is summarized in the FDA injectable PrEP approval announcement. Manufacturer information is available from ViiV Healthcare product resources.

This content is for informational purposes only and is not a substitute for professional medical advice.